Hindalco Share Price Live Updates: Hindalco’s Stock Sees a Minor Weekly Drop

The partnership will target high-tech and manufacturing risks while supporting Indian companies expanding overseas and multinationals operating in India.

Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalidomide. This led to a pronounced drop in consolidated revenues compared to the prior year. On a brighter note, the core business showed some positive growth, and total expenses saw a decrease, providing…

Kraft Heinz Q2 2026 slides: $700M investment drives share gains